Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07303153

Assessment of Quality of Life After Acute Mesenteric Ischemia

Acute mesenteric ischemia is a severe abdominal emergency associated with a poor prognosis. While numerous studies have been conducted on the incidence, outcomes, and risk factors of mesenteric ischemia, very few focus on the quality of life of patients.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service d'Anesthésie - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Astrid WELVAERT, MD

CONTACT

[email protected]

33 3 69 55 16 22

Astrid WELVAERT, MD

PRINCIPAL_INVESTIGATOR

Guillaume PHILOUZE, MD

SUB_INVESTIGATOR

Julien GODET, Statistician

SUB_INVESTIGATOR

Olivier COLLANGE, MD

SUB_INVESTIGATOR

Quentin TOURTET, MD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient (≥ 18 years)
  • Treated for mesenteric ischemia between 2010 and 2022 in the intensive care, cardiovascular, and digestive and vascular surgery departments of the Strasbourg University Hospitals

Exclusion criteria

  • Chronic mesenteric ischemia or other non-ischemic intestinal vascular pathologies such as mechanical causes.
  • Colonic ischemia

Treatment and study plan

Primary outcomes

  1. Score of GIQLI (Gastrointestinal Quality of Life Index)

    Time frame: Up to 12 months

    The GIQLI quality of life score consists of 36 items:

    the higher the score, the better the quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Astrid WELVAERT, MD

CONTACT

[email protected]

33 3 69 55 16 22

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: EQVIMA-1

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Dec 24, 2025
Registry last updated
Dec 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.